A clinical studies on biapenem in respiratory infections

Abstract

We studied the clinical efficacy and safety of biapenem (BIPM) in 5 patients with respiratory infection (pneumonia 3, and exacerbated bronchiectasis 2), who were treated with BIPM at 300mg twice a day for 7-11days.
Overall clinical effect was excellent in 2, good in 2, and poor in 1. No clinical side effect was observed. A slight increase in peripheral eosinophil in one case was the only abnormal laboratory finding.